374 related articles for article (PubMed ID: 25219498)
1. Modification of ASC1 by UFM1 is crucial for ERα transactivation and breast cancer development.
Yoo HM; Kang SH; Kim JY; Lee JE; Seong MW; Lee SW; Ka SH; Sou YS; Komatsu M; Tanaka K; Lee ST; Noh DY; Baek SH; Jeon YJ; Chung CH
Mol Cell; 2014 Oct; 56(2):261-274. PubMed ID: 25219498
[TBL] [Abstract][Full Text] [Related]
2. Modification of ERα by UFM1 Increases Its Stability and Transactivity for Breast Cancer Development.
Yoo HM; Park JH; Kim JY; Chung CH
Mol Cells; 2022 Jun; 45(6):425-434. PubMed ID: 35680375
[TBL] [Abstract][Full Text] [Related]
3. Ufmylation of ASC1 is essential for breast cancer development.
Cancer Discov; 2014 Nov; 4(11):OF10. PubMed ID: 25367951
[TBL] [Abstract][Full Text] [Related]
4. Ubiquitin-fold modifier 1 acts as a positive regulator of breast cancer.
Yoo HM; Park JH; Jeon YJ; Chung CH
Front Endocrinol (Lausanne); 2015; 6():36. PubMed ID: 25852645
[TBL] [Abstract][Full Text] [Related]
5. UFBP1, a Key Component of the Ufm1 Conjugation System, Is Essential for Ufmylation-Mediated Regulation of Erythroid Development.
Cai Y; Pi W; Sivaprakasam S; Zhu X; Zhang M; Chen J; Makala L; Lu C; Wu J; Teng Y; Pace B; Tuan D; Singh N; Li H
PLoS Genet; 2015 Nov; 11(11):e1005643. PubMed ID: 26544067
[TBL] [Abstract][Full Text] [Related]
6. Notch-1 activates estrogen receptor-alpha-dependent transcription via IKKalpha in breast cancer cells.
Hao L; Rizzo P; Osipo C; Pannuti A; Wyatt D; Cheung LW; Sonenshein G; Osborne BA; Miele L
Oncogene; 2010 Jan; 29(2):201-13. PubMed ID: 19838210
[TBL] [Abstract][Full Text] [Related]
7. Menin, a product of the MENI gene, binds to estrogen receptor to enhance its activity in breast cancer cells: possibility of a novel predictive factor for tamoxifen resistance.
Imachi H; Murao K; Dobashi H; Bhuyan MM; Cao X; Kontani K; Niki S; Murazawa C; Nakajima H; Kohno N; Yamashita H; Iwase H; Hayashi S; Ishida T; Yamauchi A
Breast Cancer Res Treat; 2010 Jul; 122(2):395-407. PubMed ID: 19847644
[TBL] [Abstract][Full Text] [Related]
8. Structural and Functional Analysis of a Novel Interaction Motif within UFM1-activating Enzyme 5 (UBA5) Required for Binding to Ubiquitin-like Proteins and Ufmylation.
Habisov S; Huber J; Ichimura Y; Akutsu M; Rogova N; Loehr F; McEwan DG; Johansen T; Dikic I; Doetsch V; Komatsu M; Rogov VV; Kirkin V
J Biol Chem; 2016 Apr; 291(17):9025-41. PubMed ID: 26929408
[TBL] [Abstract][Full Text] [Related]
9. Various phosphorylation pathways, depending on agonist and antagonist binding to endogenous estrogen receptor alpha (ERalpha), differentially affect ERalpha extractability, proteasome-mediated stability, and transcriptional activity in human breast cancer cells.
Marsaud V; Gougelet A; Maillard S; Renoir JM
Mol Endocrinol; 2003 Oct; 17(10):2013-27. PubMed ID: 12855746
[TBL] [Abstract][Full Text] [Related]
10. UFMylation: A Unique & Fashionable Modification for Life.
Wei Y; Xu X
Genomics Proteomics Bioinformatics; 2016 Jun; 14(3):140-146. PubMed ID: 27212118
[TBL] [Abstract][Full Text] [Related]
11. Activity of the antiestrogenic cajanin stilbene acid towards breast cancer.
Fu Y; Kadioglu O; Wiench B; Wei Z; Wang W; Luo M; Yang X; Gu C; Zu Y; Efferth T
J Nutr Biochem; 2015 Nov; 26(11):1273-82. PubMed ID: 26365581
[TBL] [Abstract][Full Text] [Related]
12. A novel type of E3 ligase for the Ufm1 conjugation system.
Tatsumi K; Sou YS; Tada N; Nakamura E; Iemura S; Natsume T; Kang SH; Chung CH; Kasahara M; Kominami E; Yamamoto M; Tanaka K; Komatsu M
J Biol Chem; 2010 Feb; 285(8):5417-27. PubMed ID: 20018847
[TBL] [Abstract][Full Text] [Related]
13. The GPER1/SPOP axis mediates ubiquitination-dependent degradation of ERα to inhibit the growth of breast cancer induced by oestrogen.
Zhang N; Sun P; Xu Y; Li H; Liu H; Wang L; Cao Y; Zhou K; TinghuaiWang
Cancer Lett; 2021 Feb; 498():54-69. PubMed ID: 33069770
[TBL] [Abstract][Full Text] [Related]
14. Estrogen response element and the promoter context of the human and mouse lactoferrin genes influence estrogen receptor alpha-mediated transactivation activity in mammary gland cells.
Stokes K; Alston-Mills B; Teng C
J Mol Endocrinol; 2004 Oct; 33(2):315-34. PubMed ID: 15525592
[TBL] [Abstract][Full Text] [Related]
15. A novel function of the Fe65 neuronal adaptor in estrogen receptor action in breast cancer cells.
Sun Y; Kasiappan R; Tang J; Webb PL; Quarni W; Zhang X; Bai W
J Biol Chem; 2014 May; 289(18):12217-31. PubMed ID: 24619425
[TBL] [Abstract][Full Text] [Related]
16. Coactivator-mediated estrogen response in human squamous cell carcinoma lines.
Ku TK; Crowe DL
J Endocrinol; 2007 Apr; 193(1):147-55. PubMed ID: 17400812
[TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factor is a target gene for estrogen receptor and contributes to breast cancer progression.
Applanat MP; Buteau-Lozano H; Herve MA; Corpet A
Adv Exp Med Biol; 2008; 617():437-44. PubMed ID: 18497067
[TBL] [Abstract][Full Text] [Related]
18. Cell cycle progression stimulated by tamoxifen-bound estrogen receptor-alpha and promoter-specific effects in breast cancer cells deficient in N-CoR and SMRT.
Keeton EK; Brown M
Mol Endocrinol; 2005 Jun; 19(6):1543-54. PubMed ID: 15802375
[TBL] [Abstract][Full Text] [Related]
19. Hakai acts as a coregulator of estrogen receptor alpha in breast cancer cells.
Gong EY; Park E; Lee K
Cancer Sci; 2010 Sep; 101(9):2019-25. PubMed ID: 20608937
[TBL] [Abstract][Full Text] [Related]
20. Human UFSP1 translated from an upstream near-cognate initiation codon functions as an active UFM1-specific protease.
Liang Q; Jin Y; Xu S; Zhou J; Mao J; Ma X; Wang M; Cong YS
J Biol Chem; 2022 Jun; 298(6):102016. PubMed ID: 35525273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
